Notice to Pharmacies Prime Therapeutics LLC (“Prime”), on

Prime Therapeutics LLC (“Prime”), on behalf of Blue Cross and Blue Shield of Texas, specializes in providing comprehensive pharmacy benefit management solutions to help members get the medicine they need to feel better and live well. Prime administers competitive bids and participation opportunities for the hemophilia network and specialty services networks on behalf of Blue Cross and Blue Shield of Texas. These Networks provide eligible members access to Hemophilia and specialty services under their benefit plan.

Beginning on April 1, 2023 through April 20, 2023, pharmacies may submit a competitive bid for participation in one or both of these Networks. All bids must be submitted and received by Prime no later than April 20, 2023 in order to be considered. Please contact Prime on April 1, 2023 by email at specialtycontracting@primetherapeutics.com to request an application.